• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

BactiQuant

3.19 DKK

0.00 %

Less than 1K followers

BACTIQ

First North Denmark

Industrial Goods & Services

Industrials

Overview
Financials & Estimates
Dividend
Investor consensus
Compare
0.00 %
-0.62 %
+28.11 %
-3.33 %
-17.04 %
+7.77 %
-26.21 %
-76.75 %
-77.75 %

Bactiquant operates in the industrial sector. The company has developed a technology that is used to monitor bacteria levels in water and to ensure the use and management of water resources. The company delivers its services to customers around the global market, mainly consisting of larger industrial companies that are in need of water cooling and wastewater treatment. The company has its headquarters in Horsholm.

Read more
Market cap
119.69M DKK
Turnover
27.78K DKK
Revenue
8.32M
EBIT %
-150.24 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
26.8
2026

Interim report Q2'26

3.2
2027

Annual report '26

28.4
2027

General meeting '27

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release4/28/2026, 2:52 PM

Referat af ordinær generalforsamling i BactiQuant A/S

BactiQuant
Regulatory press release4/15/2026, 11:28 AM

Trading Statement for Q1 2026 (1. januar - 31. marts 2026)

BactiQuant
Regulatory press release4/13/2026, 2:39 PM

Rettelse: Følgende meddelelse udsendt med forkert kategori: Ved den forestående generalforsamling 28. april 2026 fratræder Mette Juhl Jørgensen som bestyrelsesmedlem, men fortsætter som COO

BactiQuant

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/13/2026, 12:18 PM

Indkaldelse til ordinær generalforsamling i BactiQuant A/S

BactiQuant
Regulatory press release4/13/2026, 12:18 PM

Indkaldelse til ordinær generalforsamling i BactiQuant A/S

BactiQuant
Regulatory press release4/13/2026, 11:25 AM

Ved den forestående generalforsamling 28. april 2026 fratræder Mette Juhl Jørgensen som bestyrelsesmedlem, men fortsætter som COO

BactiQuant
Regulatory press release3/18/2026, 4:00 PM

Årsregnskab 2025: Vækst på 16% og solid likviditet sikrer godt grundlag for øget vækst.

BactiQuant
Press release3/11/2026, 7:21 AM

BioPhorum-rapport fremhæver BactiQuants on-line bakteriesensor teknologi som central case i pharma-industriens fremtidige overvågning

BactiQuant
Press release3/9/2026, 2:49 PM

BactiQuant modtager ordre på on-line bakteriesensorer fra supersygehus i hovedstadsområdet

BactiQuant
Press release3/5/2026, 12:46 PM

BactiQuant skærper fokus: Pharma bliver omdrejningspunktet for vores kommercielle strategi

BactiQuant
Regulatory press release2/4/2026, 4:01 PM

Trading Statement (periodemeddelse) for Q4 2025 (1. januar - 31. december 2025)

BactiQuant
Regulatory press release2/4/2026, 4:00 PM

Guidance for 2026 viser en forventet vækst i omsætning på mellem 20% og 50%

BactiQuant
Press release12/12/2025, 1:50 PM

BactiQuant modtager ordre på endnu en prøvetagningsrobot til Pharma

BactiQuant
Press release12/3/2025, 1:25 PM

BactiQuant indgår samarbejde med erfaren erhvervsmand om strategisk rådgivning

BactiQuant
Regulatory press release12/2/2025, 8:58 AM

Korrektion og præcisering af virksomhedsmeddelelse udsendt 01.12.2025 - 18:57: CET med titlen: BactiQuant udsteder warrants til Selskabets direktion og medarbejdere

BactiQuant
Regulatory press release12/1/2025, 5:57 PM

BactiQuant udsteder warrants til Selskabets direktion og medarbejdere

BactiQuant
Regulatory press release11/20/2025, 10:36 AM

Storaktionærmeddelelse

BactiQuant
Regulatory press release11/20/2025, 8:48 AM

Indberetning af handler foretaget af ledende medarbejdere (PDMR)

BactiQuant
Regulatory press release11/20/2025, 8:43 AM

Indberetning af handler foretaget af ledende medarbejdere (PDMR)

BactiQuant
Regulatory press release11/20/2025, 8:30 AM

Indberetning af handler foretaget af ledende medarbejdere (PDMR)

BactiQuant